Clinical Trials Directory

Trials / Completed

CompletedNCT05446610

Investigating Effects in Intestinal Permeability of Rich in Beta-glucans Pleurotus Eryngii Mushrooms Fermentation Supernatants: an Ex-vivo Study

Development of a Novel Functional Food Enriched With Beta-glucans Isolated From Edible Mushrooms of Greek Habitats

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Örebro University, Sweden · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the present study was to investigate the ability of Pleurotus eryngii mushrooms fermentation products (FS) to counteract induced intestinal hyperpermeability in human colonic tissues in an ex vivo system.

Detailed description

Collection of colon biopsies through sigmoidoscopy procedure will take place and the collected biopsies will be mounted in Ussing Chambers. Already collected fermentation supernatants will be added to the mucosal side of the biopsy together with a stressor and two permeability markers, in order to investigate the effects of the fibre fractions on both paracellular and transcellular permeability.

Conditions

Interventions

TypeNameDescription
OTHERFermented product of Pleurotus eryngii mushroomI Stimulation of human colonic biopsies with the fermented product of Pleurotus eryngii mushroom

Timeline

Start date
2020-03-17
Primary completion
2020-09-18
Completion
2022-06-17
First posted
2022-07-06
Last updated
2022-07-06

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05446610. Inclusion in this directory is not an endorsement.